Pure Peptides.
Verified Quality.
The industry standard for high-purity research materials. Third-party tested, same-day shipping, and total transparency.
Available Inventory
Validated Batch Synthesis - Ready to Ship
Cagrilintide (5mg) / Tirz (10mg)
- Triple-Receptor Agonist: Combines amylin, GIP, and GLP-1 pathways in one formulation
- Multi-Pathway Engagement: Three independent satiety and metabolic control mechanisms
- Research Blend: 5mg Cagrilintide + 10mg Tirzepatide, ≥98% purity each component
$149.00
Thymosin Alpha-1
- 28-Amino Acid Immunomodulator: N-terminal fragment of prothymosin alpha (Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN), originally isolated from thymus 1977, 3,000+ publications, thymalfasin (Zadaxin) approved in 35+ countries
- Pleiotropic Immune Activation: TLR2/3/4/7/9 agonist, dendritic cell activation, T-cell maturation (CD4+/CD8+), Th1 polarization (IL-2/IL-12/IFN-γ↑), NK cell enhancement, PD-1/Tim-3 exhaustion marker reduction
- Clinical Status: FDA orphan drug (DiGeorge anomaly, melanoma, hepatitis B, HCC), China approved for hepatitis B/HCC, COVID-19 mortality reduction (11.11% vs 30.00%, Liu et al. 2020), sepsis meta-analysis 41% mortality reduction
$49.00
Tesofensine Capsules (500mcg) 100 Count
- Triple monoamine reuptake inhibitor (TRI) potently inhibiting presynaptic reuptake of serotonin, norepinephrine, and dopamine with IC₅₀ values: NET 1.7-3.2 nM, SERT 11 nM, DAT 8.0-65 nM
- Produces approximately twice the weight loss of currently marketed anti-obesity medications; Phase II trials: 9-11% body weight reduction over 24 weeks at therapeutic doses (0.5-1.0 mg)
- FDA orphan drug designation for Tesomet (tesofensine + metoprolol) in Prader-Willi syndrome (March 2021) and hypothalamic obesity (July 2021); exceptionally long half-life (~9 days) enabling once-daily dosing
$170.00
TB-500 (Thymosin Beta-4) (43aa)
- Thymosin Beta-4 Derivative: 43-amino acid peptide (Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES-OH), derived from naturally occurring thymosin beta-4 (70-80% of beta-thymosins), 2,000+ publications, N-terminal acetylation for enhanced stability
- Multi-Pathway Regeneration: G-actin sequestration (Kd 0.5-0.7 μM), cell migration promotion, VEGF upregulation via Wnt/β-catenin/Lef-1, angiogenesis, PI3K/Akt/eNOS survival pathway, anti-fibrotic via TGF-β1 suppression
- Clinical Status: No FDA-approved human drug, all therapeutic data preclinical (wound healing, cardiac repair, pulmonary fibrosis, Alzheimer's neuroprotection), extensive safety profile in animal models
$36.40
The Gold Standard
in Purity.
We bridge the gap between complex laboratory synthesis and simple, reliable procurement. Every order is a promise of quality.
99%+ PURITY GUARANTEE
Every batch is tested via HPLC/MS to ensure the highest chemical integrity.
SAME-DAY SHIPPING
Orders placed before 2PM EST ship same-day with tracked express delivery.
DISCREET & SECURE
Plain packaging and secure encrypted checkout protect your research privacy.
EXPERT SUPPORT
Our team is available 24/7 for order assistance and technical data support.
Understanding the Science
We believe transparency is the foundation of research trust.
HPLC Tested
High-Performance Liquid Chromatography proves the exact chemical identity.
Lyophilized
Freeze-dried powder form ensures 24+ months of shelf stability.
Batch COA
Certificate of Analysis provided with every lot for total transparency.
Institutional Researcher?
We offer bulk synthesis reservations and technical data sheet integration for longitudinal study planning.
Research Series
Browse Catalog Collections
